Filing Details
- Accession Number:
- 0001312548-11-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-06 13:00:00
- Reporting Period:
- 2011-04-04
- Filing Date:
- 2011-04-06
- Accepted Time:
- 2011-04-06 17:34:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1323885 | Atricure Inc. | ATRC | Surgical & Medical Instruments & Apparatus (3841) | 341940305 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1312548 | Discovery Group I, Llc | 191 N. Wacker Drive Suite 1685 Chicago IL 60606 | No | No | Yes | No | |
1323510 | R Michael Murphy | C/O Discovery Group I, Llc 191 N. Wacker Drive Suite 1685 Chicago IL 60606 | No | No | Yes | No | |
1323511 | J Daniel Donoghue | C/O Discovery Group I, Llc 191 N. Wacker Drive Suite 1685 Chicago IL 60606 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-04-04 | 1,768 | $11.50 | 1,611,356 | No | 4 | P | Indirect | By Discovery Equity Partners, L.P. |
Common Stock | Acquisiton | 2011-04-05 | 800 | $11.49 | 1,612,156 | No | 4 | P | Indirect | By Discovery Equity Partners, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Discovery Equity Partners, L.P. |
No | 4 | P | Indirect | By Discovery Equity Partners, L.P. |
Footnotes
- Discovery Group I, LLC is the General Partner of Discovery Equity Partners, L.P., which is a discretionary client of the reporting person,that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent ofits pecuniary interest therein.
- This transaction was executed in multiple trades at prices ranging from $11.48 to $11.50. The price reported above reflects the weightedaverage purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected